Announce Date | 02/03/2025 |
EPS Normalized Actual | $2.62 (Beat by $0.23) |
EPS GAAP Actual | $2.62 (Beat by $0.23) |
Revenue Actual | $0.954288B |
Revenue Surprise | Beat by $954.288M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $3.35283 |
EPS GAAP Estimate | $3.35283 |
Revenue Estimate | $1.124498833B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 0 | INF | 0 | 0 | 4 |
Dec 2027 | 17.47 | 25.04 | 17.22996 | 17.72862 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 2.63 | 2.63 | 0.954288B | 5.52% | 954.29M |
FQ3 2024 (Sep 2024) | 2.82 | 2.82 | 0.975543B | 6.15% | 975.54M |
FQ2 2024 (Jun 2024) | 2.46 | 2.46 | 1.00358B | 5.97% | 1003.58M |
FQ1 2024 (Mar 2024) | 2.84 | 2.84 | 0.964095B | 6.63% | 964.1M |
FQ4 2023 (Dec 2023) | 2.3411 | 2.3411 | 0.901601B | 8.1% | 901.6M |
FQ3 2023 (Sep 2023) | 0 | 0 | 0.915527B | 8.07% | 915.53M |
FQ2 2023 (Jun 2023) | 2.7 | 2.7 | 0.94363B | 8.8% | 943.63M |
FQ1 2023 (Mar 2023) | 2.58 | 2.58 | 0.900195B | 100% | 900.2M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
3.35283
Consensus Revenue Estimates
1.124498833B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.89 | -- | 3.81384 | 3.95079 | 3 |
FQ2 2027 (Jun 2027) | 4.13 | -- | 4.04914 | 4.19454 | 5 |
FQ1 2027 (Mar 2027) | 3.81 | -- | 3.73688 | 3.87105 | 3 |
FQ4 2026 (Oct 2026) | 3.68 | -- | 3.62682 | 3.75661 | 3 |
FQ3 2026 (Jul 2026) | 3.9 | -- | 3.84364 | 3.98119 | 3 |
FQ2 2026 (Jun 2026) | 3.9 | -- | 3.86151 | 3.94055 | 3 |
FQ1 2026 (Mar 2026) | 3.6 | -- | 3.56447 | 3.63743 | 3 |
FQ4 2025 (Oct 2025) | 3.146 | 16.4 | 3.10054 | 3.21149 | 3 |
FQ3 2025 (Jul 2025) | 3.28125 | 14.06 | 3.23383 | 3.34956 | 3 |
FQ2 2025 (Jun 2025) | 3.35283 | 26.63 | 3.31974 | 3.38769 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.22B | -- | 1.21B | 1.24B | 3 |
FQ2 2027 (Jun 2027) | 1.24B | -- | 1.22B | 1.26B | 3 |
FQ1 2027 (Mar 2027) | 1.18B | -- | 1.17B | 1.2B | 3 |
FQ4 2026 (Oct 2026) | 1.21B | -- | 1.2B | 1.23B | 4 |
FQ3 2026 (Jul 2026) | 1.25B | -- | 1.24B | 1.27B | 4 |
FQ2 2026 (Jun 2026) | 1.25B | -- | 1.24B | 1.26B | 4 |
FQ1 2026 (Mar 2026) | 1.18B | -- | 1.17B | 1.19B | 4 |
FQ4 2025 (Oct 2025) | 1.09B | 12.25 | 1.08B | 1.1B | 2 |
FQ3 2025 (Jul 2025) | 1.11B | 12.32 | 1.1B | 1.13B | 2 |
FQ2 2025 (Jun 2025) | 1.12B | 10.75 | 1.12B | 1.13B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 2.63 | 2.63 | 100% | |
FQ3 2024 (Sep 2024) | 2.82 | 2.82 | 100% | |
FQ2 2024 (Jun 2024) | 2.46 | 2.46 | 100% | |
FQ1 2024 (Mar 2024) | 2.84 | 2.84 | 100% | |
FQ4 2023 (Dec 2023) | 2.3411 | 2.3411 | 100% | |
FQ3 2023 (Sep 2023) | 0 | 0 | NAN% | |
FQ2 2023 (Jun 2023) | 2.7 | 2.7 | 100% | |
FQ1 2023 (Mar 2023) | 2.58 | 2.58 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0.95B | $954.29M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.98B | $975.54M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1B | $1003.58M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.96B | $964.1M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.9B | $901.6M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.92B | $915.53M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.94B | $943.63M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.9B | $900.2M | 100% |